Scleroderma Research in Action — Understanding Clinical Trials (2025)

Clinical trials can seem complex—this session helps break down what people living with scleroderma need to know. Experts from the Scleroderma Research Foundation, leading academic institutions, and pharmaceutical companies come together to demystify the clinical trial process and highlight the latest advances in scleroderma research.

Featuring Gregory Gordon, MD, JD (Scleroderma Research Foundation), Dr. Dinesh Khanna (University of Michigan), Dr. Lauren Reinke-Breen (AbbVie), and Dr. Kremena Simitchieva (Boehringer Ingelheim), this presentation covers:
New and Emerging Therapies: What patients need to know now
CONQUEST Clinical Trial: Key design elements and patient benefits
Panel Discussion: How pharma decides where to invest in drug development